gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Coronary Stenosis

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Coronary Stenosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
D'Amico, R; Di Girolamo, A; Ferraresi, S; Fiocchi, F; Ligabue, G; Modena, MG; Rossi, R; Sgura, F; Torricelli, P	1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Coronary Stenosis

Article	Year
Chronic total coronary occlusion in patients with intermediate viability: value of low-dose dobutamine and contrast-enhanced 3-T MRI in predicting functional recovery in patients undergoing percutaneous revascularisation with drug-eluting stent. La Radiologia medica, 2009, Volume: 114, Issue:5 Topics: Aged; Cardiotonic Agents; Chronic Disease; Contrast Media; Coronary Stenosis; Dobutamine; Drug-Eluting Stents; Female; Heterocyclic Compounds; Humans; Linear Models; Magnetic Resonance Imaging; Male; Myocardial Revascularization; Organometallic Compounds; Predictive Value of Tests; Recovery of Function; Treatment Outcome	2009

Article

Year

Chronic total coronary occlusion in patients with intermediate viability: value of low-dose dobutamine and contrast-enhanced 3-T MRI in predicting functional recovery in patients undergoing percutaneous revascularisation with drug-eluting stent.

La Radiologia medica, 2009, Volume: 114, Issue:5

Topics: Aged; Cardiotonic Agents; Chronic Disease; Contrast Media; Coronary Stenosis; Dobutamine; Drug-Eluting Stents; Female; Heterocyclic Compounds; Humans; Linear Models; Magnetic Resonance Imaging; Male; Myocardial Revascularization; Organometallic Compounds; Predictive Value of Tests; Recovery of Function; Treatment Outcome

2009